Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Avinash K. Shetty is active.

Publication


Featured researches published by Avinash K. Shetty.


The Journal of Infectious Diseases | 2005

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.

Esther J. Lee; Rami Kantor; Lynn S. Zijenah; Wayne Sheldon; Lynda Emel; Patrick Mateta; Elizabeth Johnston; Jennifer Wells; Avinash K. Shetty; Hoosen M. Coovadia; Yvonne Maldonado; Samuel Adeniyi Jones; Lynne M. Mofenson; Christopher H. Contag; Mary T. Bassett; David Katzenstein

Single-dose nevirapine reduces intrapartum human immunodeficiency virus 1 type (HIV-1) transmission but may also select for nonnucleoside reverse-transcriptase inhibitor (NNRTI) resistance in breast milk (BM) and plasma. Among 32 Zimbabwean women, median 8-week postpartum plasma and BM HIV-1 RNA levels were 4.57 and 2.13 log(10) copies/mL, respectively. BM samples from women with laboratory-diagnosed mastitis (defined as elevated BM Na(+) levels) were 5.4-fold more likely to have HIV-1 RNA levels above the median. BM RT sequences were not obtained for 12 women with BM HIV-1 RNA levels below the lower limit of detection of the assay used. In 20 paired BM and plasma samples, 65% of BM and 50% of plasma RT sequences had NNRTI-resistance mutations, with divergent mutation patterns.


International Journal of Std & Aids | 2005

The feasibility of voluntary counselling and HIV testing for pregnant women using community volunteers in Zimbabwe

Avinash K. Shetty; Miriam Mhazo; Sostain Moyo; Andrea von Lieven; Patrick Mateta; David Katzenstein; Yvonne Maldonado; David Hill; Mary T. Bassett

The purpose of this pilot project was to assess the feasibility and acceptability of voluntary counselling and HIV testing (VCT) by pregnant women using community volunteers in Zimbabwe to prevent mother to child transmission (MTCT) of HIV. From July 1999 to June 2001, a short-course zidovudine (ZDV)-based perinatal HIV prevention programme was initiated in two antenatal clinics. Community volunteers, recruited from local community organizations, underwent a two-week training course in VCT, which included HIV/AIDS facts, systematic counselling approach, and practical counselling techniques using scripts and role-play. Rapid HIV testing was performed after informed consent. Lay counsellors conducted individual pre- and post-test counselling for HIV. A total of 35 women community volunteers were trained in VCT; 34 graduated and committed to work four hours per week in the clinic. Of the 6051 pregnant women presenting for antenatal clinics (ANC), 1824 (30%) underwent pre-test counselling and 1547 (26%) were tested, and 429 (28%) were HIV infected. Overall, 1283 (83%) returned for their test results including 406 (95%) of HIV-infected women. Of the 406 HIV-infected women who collected their test results, only 203 (50%) opted for ZDV prophylaxis to prevent MTCT of HIV. Over the two-year study period, two counsellors died and three sought employment at other organizations. Adherence to duty roster was 97% and no breach of confidentiality was reported. Despite many challenges, VCT delivered by community volunteers is feasible and acceptable for pregnant women aiming to reduce their risk of transmitting HIV to their infants. This programme is being implemented at several urban and rural MTCT sites in Zimbabwe and can serve as a model for other resource-poor countries.


Pediatric Pulmonology | 2000

Intravenous ribavirin therapy for adenovirus pneumonia

Avinash K. Shetty; Hayley A. Gans; Samuel So; Maria T. Millan; Ann M. Arvin; Kathleen Gutierrez

We report on the effectiveness of intravenous ribavirin for severe adenoviral pneumonia in a 10‐month‐old male following orthotopic liver transplantation. On day 20 post‐transplantation, he developed high fever, marked respiratory compromise, and hypoxemia. The chest radiograph showed bilateral pulmonary infiltrates. Samples of bronchoalveolar lavage fluid grew adenovirus, serotype 1. Marked clinical and radiological improvement was noted after intravenous ribavirin therapy. A prospective clinical trial is needed to determine the efficacy of ribavirin therapy for severe adenovirus disease. Pediatr Pulmonol. 2000; 29:69–73.


Journal of The International Association of Physicians in Aids Care (jiapac) | 2005

Screening for Psychological Morbidity in HIV-Infected and HIV-Uninfected Pregnant Women Using Community Counselors in Zimbabwe

Lynda Stranix-Chibanda; Dixon Chibanda; Albert Chingono; Elizabeth T. Montgomery; Jennifer Wells; Yvonne Maldonado; Tsungai Chipato; Avinash K. Shetty

Objective: To examine the prevalence of psychological morbidity in HIV-infected and uninfected pregnant women seeking antenatal care in Zimbabwe. Methods: Pregnant women were screened for psychological morbidity at the initial antenatal care visit using the 14-item Shona Symptom Questionnaire (SSQ) before voluntary HIV counseling and testing (VCT). The primary outcome measure was “cases,” as determined by a SSQ score of= 8. Demographic characteristics and HIV status were compared between cases and noncases to determine the risk factors for psychological morbidity. Results: Of the 437 participants, psychological morbidity was detected in 73 (17%) women before undergoing VCT. Risk factors for psychological morbidity included having a spouse older than 35 years of age. HIV infection by itself was not a risk factor for psychological morbidity for women. Conclusions: There is a high burden of psychological morbidity among pregnant women in Zimbabwe. Mental health services should be integrated into antenatal care to improve psychological health for all women in Zimbabwe.


International Journal of Std & Aids | 2006

Perceived risks and benefits of HIV testing, and predictors of acceptance of HIV counselling and testing among pregnant women in Zimbabwe

Susanne P. Martin-Herz; Avinash K. Shetty; Mary T. Bassett; Catherine Ley; Miriam Mhazo; Sostain Moyo; Arnd M. Herz; David Katzenstein

This project evaluated perceived risks and benefits and determined predictors of acceptance of voluntary HIV counselling and testing (VCT) among pregnant women in Zimbabwe. One hundred and seventy pregnant women attending an urban antenatal clinic were surveyed. Implications of a negative or positive HIV test result and of telling a partner or community members that one is HIV positive were queried. Forty women (23.5%) consented to VCT, and 16 (40%) were HIV positive. Women who saw VCT as lower risk (odds ratio [OR] = 2.3, 95% confidence interval [CI] [1.1–5.0]) and women who had had a stillbirth or child die (OR = 0.4, 95% CI [0.16–0.97]) were more likely to consent. Prenatal HIV VCT offers the best opportunity for prevention of mother-to-child transmission of HIV; however, less than 25% of women consented. If such interventions are to be successful, attention must be directed towards developing culturally appropriate strategies to address womens concerns and improve future acceptance of VCT in Zimbabwe.


Medical and Pediatric Oncology | 1999

Role of chemotherapy in the treatment of infantile fibrosarcoma

Avinash K. Shetty; Lolie C. Yu; Renee V. Gardner; Raj P. Warrier


Current Problems in Pediatrics | 2000

Sarcoidosis in children.

Avinash K. Shetty; Abraham Gedalia


Infectious Diseases of the Fetus and Newborn (Seventh Edition) | 2011

CHAPTER 21 – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the Infant

Avinash K. Shetty; Yvonne Maldonado


Principles and Practice of Pediatric Infectious Diseases (Fifth Edition) | 2018

227 – Rubeola Virus: Measles and Subacute Sclerosing Panencephalitis

Yvonne Maldonado; Avinash K. Shetty


Archive | 2008

Epidemiology and Prevention of HIV Infection in Children and Adolescents

Avinash K. Shetty; Yvonne Maldonado

Collaboration


Dive into the Avinash K. Shetty's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D.A. Katzenstein

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge